Jack Price

Jack Price

Auto-generated profile, based on publicly available information

Jack Price

Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2011 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
CAC Anacker
C Anacker
PZP A Zunszain
P A Zunszain
ACAnnamaria Cattaneo
Annamaria Cattaneo
LCL A Carvalho
L A Carvalho
MGM J Garabedian
M J Garabedian
CPC M Pariante
C M Pariante
Antidepressants increase adult hippocampal neurogenesis in animal models, but the underlying molecular mechanisms are unknown. In this study, we used human hippocampal progenitor cells to investigate the molecular pathways involved in the antidepressant-induced modulation of neurogenesis. Because our previous studies have shown that antidepressants regulate glucocorticoid receptor (GR) function, we specifically tested whether the GR may be involved in the effects of these drugs on neurogenesis. We found that treatment (for 3–10 days) with the antidepressant, sertraline, increased neuronal differentiation via a GR-dependent mechanism. Specifically, sertraline increased both immature, doublecortin (Dcx)-positive neuroblasts (+16%) and mature, microtubulin-associated protein-2 (MAP2)-positive neurons (+26%). This effect was abolished by the GR-antagonist, RU486. Interestingly, progenitor cell proliferation, as investigated by 5′-bromodeoxyuridine (BrdU) incorporation, was only increased when cells were co-treated with sertraline and the GR-agonist, dexamethasone, (+14%) an effect which was also abolished by RU486. Furthermore, the phosphodiesterase type 4 (PDE4)-inhibitor, rolipram, enhanced the effects of sertraline, whereas the protein kinase A (PKA)-inhibitor, H89, suppressed the effects of sertraline. Indeed, sertraline increased GR transactivation, modified GR phosphorylation and increased expression of the GR-regulated cyclin-dependent kinase-2 (CDK2) inhibitors, p27Kip1 and p57Kip2. In conclusion, our data suggest that the antidepressant, sertraline, increases human hippocampal neurogenesis via a GR-dependent mechanism that requires PKA signaling, GR phosphorylation and activation of a specific set of genes. Our data point toward an important role for the GR in the antidepressant-induced modulation of neurogenesis in humans.

9 November 2011 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PZPatricia A Zunszain
Patricia A Zunszain
CAChristoph Anacker
Christoph Anacker
ACAnnamaria Cattaneo
Annamaria Cattaneo
SCShanas Choudhury
Shanas Choudhury
KMKsenia Musaelyan
Ksenia Musaelyan
CPCarmine M Pariante
Carmine M Pariante

6 May 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CAChristoph Anacker
Christoph Anacker
ACAnnamaria Cattaneo
Annamaria Cattaneo
KMKsenia Musaelyan
Ksenia Musaelyan
PZPatricia A. Zunszain
Patricia A. Zunszain
MHMark Horowitz
Mark Horowitz
CPCarmine M. Pariante
Carmine M. Pariante
Stress and glucocorticoid hormones regulate hippocampal neurogenesis, but the molecular mechanisms mediating these effects are poorly understood. Here we identify the glucocorticoid receptor (GR) target gene, serum- and glucocorticoid-inducible kinase 1 (SGK1), as one such mechanism. Using a human hippocampal progenitor cell line, we found that a small molecule inhibitor for SGK1, GSK650394, counteracted the cortisol-induced reduction in neurogenesis. Moreover, gene expression and pathway analysis showed that inhibition of the neurogenic Hedgehog pathway by cortisol was SGK1-dependent. SGK1 also potentiated and maintained GR activation in the presence of cortisol, and even after cortisol withdrawal, by increasing GR phosphorylation and GR nuclear translocation. Experiments combining the inhibitor for SGK1, GSK650394, with the GR antagonist, RU486, demonstrated that SGK1 was involved in the cortisol-induced reduction in progenitor proliferation both downstream of GR, by regulating relevant target genes, and upstream of GR, by increasing GR function. Corroborating the relevance of these findings in clinical and rodent settings, we also observed a significant increase of SGK1 mRNA in peripheral blood of drug-free depressed patients, as well as in the hippocampus of rats subjected to either unpredictable chronic mild stress or prenatal stress. Our findings identify SGK1 as a mediator for the effects of cortisol on neurogenesis and GR function, with particular relevance to stress and depression.

6 December 2012 in Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
CAChristoph Anacker
Christoph Anacker
ACAnnamaria Cattaneo
Annamaria Cattaneo
ALAlessia Luoni
Alessia Luoni
KMKsenia Musaelyan
Ksenia Musaelyan
PZPatricia A Zunszain
Patricia A Zunszain
CPCarmine M Pariante
Carmine M Pariante
Stress and glucocorticoid hormones regulate hippocampal neurogenesis, but the molecular mechanisms underlying their effects are unknown. We, therefore, investigated the molecular signaling pathways mediating the effects of cortisol on proliferation, neuronal differentiation, and astrogliogenesis, in an immortalized human hippocampal progenitor cell line. In addition, we examined the molecular signaling pathways activated in the hippocampus of prenatally stressed rats, characterized by persistently elevated glucocorticoid levels in adulthood. In human hippocampal progenitor cells, we found that low concentrations of cortisol (100 nM) increased proliferation (+16%), decreased neurogenesis into microtubule-associated protein 2 (MAP2)-positive neurons (−24%) and doublecortin (Dcx)-positive neuroblasts (−21%), and increased differentiation into S100β-positive astrocytes (+23%). These effects were dependent on the mineralocorticoid receptor (MR) as they were abolished by the MR antagonist, spironolactone, and mimicked by the MR-agonist, aldosterone. In contrast, high concentrations of cortisol (100 μM) decreased proliferation (−17%) and neuronal differentiation into MAP2-positive neurons (−22%) and into Dcx-positive neuroblasts (−27%), without regulating astrogliogenesis. These effects were dependent on the glucocorticoid receptor (GR), blocked by the GR antagonist RU486, and mimicked by the GR-agonist, dexamethasone. Gene expression microarray and pathway analysis showed that the low concentration of cortisol enhances Notch/Hes-signaling, the high concentration inhibits TGFβ-SMAD2/3-signaling, and both concentrations inhibit Hedgehog signaling. Mechanistically, we show that reduced Hedgehog signaling indeed critically contributes to the cortisol-induced reduction in neuronal differentiation. Accordingly, TGFβ-SMAD2/3 and Hedgehog signaling were also inhibited in the hippocampus of adult prenatally stressed rats with high glucocorticoid levels. In conclusion, our data demonstrate novel molecular signaling pathways that are regulated by glucocorticoids in vitro, in human hippocampal progenitor cells, and by stress in vivo, in the rat hippocampus.

1 May 2006 in Experimental Neurology
Verified
Journal Article
Closed access
KPKenneth Pollock
Kenneth Pollock
PSPaul Stroemer
Paul Stroemer
SPSara Patel
Sara Patel
LSLara Stevanato
Lara Stevanato
AHAndrew Hope
Andrew Hope
JSJohn D. Sinden
John D. Sinden

1 January 2004 in NeuroImage
Verified
Journal Article
Closed access
MMMike Modo
Mike Modo
KMKaren Mellodew
Karen Mellodew
DCDiana Cash
Diana Cash
SFScott E Fraser
Scott E Fraser
TMThomas J Meade
Thomas J Meade
SWSteven C.R Williams
Steven C.R Williams